Midostaurin Capsules (Mistaurin 25mg Capsules)

25mg Capsule, Box

4.5 (154)

7,500

Mistaurin 25mg Capsule (Midostaurin) is a chemotherapy medication used to treat acute myeloid leukemia (AML) with a FLT3 gene mutation, as well as aggressive systemic mastocytosis, mast cell leukemia, and systemic mastocytosis with hematological neoplasm. It works by blocking receptor tyrosine kinase enzymes involved in cancer cell signaling, stopping the growth and spread of cancer cells.

Description

Introduction of Mistaurin 25mg Capsule:

Mistaurin 25mg Capsule comprises of the dynamic fixing Midostaurin. It is a chemotherapy medication showed to treat grown-ups with intense myeloid leukemia that is caused because of the deformity in the quality called FLT3.

Intense myeloid leukemia happens when kind of white platelets called myeloid cells are delivered in a tremendous sum by the body. This medication is likewise suggested for patients with malignant growth in pole cells, which occurs because of the development of such a large number of pole cells (a kind of White Blood Cells).

Uses of Mistaurin 25mg Capsule:

  • Mistaurin 25mg Capsule is shown to treat the accompanying circumstances:
  • Recently analyzed Acute Myeloid Leukemia (AML), in blend with other chemotherapy medicines.
  • Forceful fundamental mastocytosis.
  • Pole cell leukemia.
  • Foundational mastocytosis with hematological neoplasm.

Mechanism of Action of Mistaurin 25mg Capsule:

Mistaurin 25 mg Capsule targets and blocks the activity of compounds called different receptor tyrosine kinases in the malignant growth cells. It restrains the receptors in development factor, undifferentiated organisms, and tyrosine kinase compounds by intruding on the disease cell flagging. This, thusly, stops the development and spread of malignant growth cells.

Contact Us

Info Table
Packaging Size 4 Capsules In 1 Pack
Brand Mistaurin 25mg Capsules
Composition Midostaurin 25mg
Manufacturer GLENMARK
Treatment Pole cell leukemia.
Prescription/Non prescription Prescription
Country of Origin Made in India
Vendor Info
Benefits
Reviews

Description

Introduction of Mistaurin 25mg Capsule:

Mistaurin 25mg Capsule comprises of the dynamic fixing Midostaurin. It is a chemotherapy medication showed to treat grown-ups with intense myeloid leukemia that is caused because of the deformity in the quality called FLT3.

Intense myeloid leukemia happens when kind of white platelets called myeloid cells are delivered in a tremendous sum by the body. This medication is likewise suggested for patients with malignant growth in pole cells, which occurs because of the development of such a large number of pole cells (a kind of White Blood Cells).

Uses of Mistaurin 25mg Capsule:

  • Mistaurin 25mg Capsule is shown to treat the accompanying circumstances:
  • Recently analyzed Acute Myeloid Leukemia (AML), in blend with other chemotherapy medicines.
  • Forceful fundamental mastocytosis.
  • Pole cell leukemia.
  • Foundational mastocytosis with hematological neoplasm.

Mechanism of Action of Mistaurin 25mg Capsule:

Mistaurin 25 mg Capsule targets and blocks the activity of compounds called different receptor tyrosine kinases in the malignant growth cells. It restrains the receptors in development factor, undifferentiated organisms, and tyrosine kinase compounds by intruding on the disease cell flagging. This, thusly, stops the development and spread of malignant growth cells.

Contact Us

Reviews

There are no reviews yet.

Be the first to review “Midostaurin Capsules (Mistaurin 25mg Capsules)”

Your email address will not be published. Required fields are marked *

Frequently Asked Questions

From sourcing to delivery, we ensure reliability at every step. Our operations follow strict quality and regulatory standards.

What is Mistaurin 25mg Capsule used for?
Mistaurin 25mg Capsule (Midostaurin) is a chemotherapy medicine used to treat acute myeloid leukemia (AML) with a FLT3 gene mutation, as well as aggressive systemic mastocytosis, mast cell leukemia, and systemic mastocytosis with hematological neoplasm.
It blocks receptor tyrosine kinase enzymes involved in cancer cell signaling, which stops the growth and spread of cancer cells.
For newly diagnosed AML, it’s used in combination with other chemotherapy medicines. For the other indications, it may be used as directed by your doctor.
It’s a blood cancer that occurs when the body produces an excessive amount of white blood cells called myeloid cells.
It’s a cancer involving mast cells (a type of white blood cell) that occurs due to the excessive development of these cells in the body.
For detailed clinical and safety information, refer to MedlinePlus Drug Information, a trusted external medical resource.

Related products